Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 25/11/20

Trade details

Type
Insider sale
Amount
$949,900
Shares · price
2,000 sh · $474.95 a share
Held after
130 sh
Trade date
25/11/19
Filed
25/11/20
Days to filing
1 days

Sold 93.9% of holdings

Share of holding sold
93.9%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/20~25/12/19

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02

Martine A. Rothblatt, Chairman — sold $949.9K of United Therapeutics UTHR · 93.9% of holdings · 10b5-1 plan | Whalegun